CVS Health Corporation vs Pfizer, Inc. — Stock Comparison

CVS Health Corporation (CVS) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

Q·Score Winner
CVS Health Corporation
CVS6.4/10vs 6.2/10

CVS Health Corporation narrowly edges Pfizer, Inc. on Q·Score (6.4 vs 6.2 out of 10), led by Sentiment (8.3 vs 5.2) and Growth (8.1 vs 5.1). Pfizer, Inc. scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for PFE (+11.4%) than for CVS (+9.3%).

Price Performance

Normalised to 100 at period start — shows relative performance.

Loading…
CVSPFE

Q·Score Breakdown

6.4
Neutral
Overall
6.2
Neutral
3.9
Quality
6.4
6.4
Health
7
8.1
Growth
5.1
6.4
Valuation
7
8.3
Sentiment
5.2
CVS

86% of 28 covering analysts have a positive rating.

low return on equity (4%).

PFE

Consistently beats earnings estimates (4/4 quarters).

earnings contracting 10% year-over-year.

Analyst Consensus

Bullish
+9.3%
Target $102.08
26 analysts
Neutral
+11.4%
Target $29.19
27 analysts

Fundamentals

CVS
PFE
41.0×
Trailing P/E
20.0×
11.2×
Forward P/E
9.2×
0.72%
Profit Margin
11.83%
13.39%
Gross Margin
74.80%
3.75%
ROE
8.31%
6.10%
Revenue Growth
5.40%
63.10%
Earnings Growth
-10.10%
0.59
Beta
0.30
2.89%
Dividend Yield
6.56%
$119.1B
Market Cap
$149.3B
52-Week Range
CVS
$5987% of range$98
PFE
$2355% of range$29

Frequently Asked Questions

CVS vs PFE: which stock scores better overall?

Based on Q·Score, CVS Health Corporation (CVS) scores 6.4/10 versus Pfizer, Inc. (PFE) at 6.2/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: CVS or PFE?

CVS Health Corporation (CVS) scores higher on Growth (8.1/10 vs 5.1/10). CVS Health Corporation reports revenue growth (6.1% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is CVS or PFE more attractively valued?

Pfizer, Inc. (PFE) scores higher on Valuation (7/10 vs 6.4/10). CVS trades at 11.2× P/E versus PFE at 9.2×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about CVS vs PFE?

There are 26 analysts covering CVS with a consensus price target of $102.08, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: CVS or PFE?

Pfizer, Inc. (PFE) scores higher on Quality (6.4/10 vs 3.9/10). Net profit margin: CVS at 0.7%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: CVS or PFE?

Pfizer, Inc. (PFE) scores higher on Financial Health (7/10 vs 6.4/10). Market beta: CVS at 0.59, PFE at 0.30. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of CVS and PFE?

CVS Health Corporation (CVS) has a market capitalisation of $119.1B, while Pfizer, Inc. (PFE) has a market cap of $149.3B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Do CVS or PFE pay dividends?

CVS pays a dividend yield of 2.89%, while PFE pays a dividend yield of 6.56%. Dividend yields fluctuate with share price and company payout decisions.

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026